Chemours Q3 reported profit includes $150 million of PFAS-insurance proceeds

Q3 sales were $1.540 billion, up 3% year on year. GAAP net income was $196 million ($1.29 per diluted share) and adjusted net income was $31 million ($0.21 adjusted EPS).

Chemours said GAAP income included $150 million of PFAS-insurance proceeds. Its adjusted measures exclude litigation-related items.

Adjusted EBITDA was $200 million. Its Q4 adjusted-EBITDA range of $160 million–$185 million is guidance.

Read the official primary record. Sources checked 2026-11-03T09:36:05.655Z.

AI-assisted reporting checked against official primary records; not personalised investment advice. The image is a CapKet original conceptual illustration and does not depict an actual issuer facility or event.

Recorded source observation: 3 Nov 2026, 15:06:05 IST. This is a source-check timestamp, not a market quote or a new article update.